Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer
Purpose: While brachytherapy is often used concurrently with flap reconstruction following surgical ablation for head and neck cancer, it remains unclear whether it increases morbidity in the particularly high risk subset of patients undergoing salvage treatment for recurrent head and neck cancer (...
Main Authors: | Peter W. Henderson, David I. Kutler, Bhupesh Parashar, David M. Otterburn, Marc A. Cohen, Jason A. Spector |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-08-01
|
Series: | Journal of Contemporary Brachytherapy |
Subjects: | |
Online Access: | https://www.termedia.pl/Neither-high-dose-nor-low-dose-brachytherapy-increases-flap-morbidity-in-salvage-treatment-of-recurrent-head-and-neck-cancer,54,28243,1,1.html |
Similar Items
-
Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
by: Justin Barnes, et al.
Published: (2019-07-01) -
Brachytherapy in paediatric malignancies – review of indications
by: Jacek Fijuth
Published: (2010-07-01) -
A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
by: Benjamin W. Fischer-Valuck, et al.
Published: (2019-12-01) -
Current status of brachytherapy in cancer treatment – short overview
by: Janusz Skowronek
Published: (2017-12-01) -
Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma
by: Andrea Vavassori, et al.
Published: (2019-10-01)